The branched-chain fatty acid valproic acid (VPA) has been shown to possess HDAC inhibitory properties and to affect the growth and survival of tumour cells in vitro and in vivo (Cinatl et al, 1996; Blaheta et al, 2005). The gene discussed is HDAC9; the disease is neoplasm.